Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 11 02:34PM ET
0.8955
Dollar change
+0.0156
Percentage change
1.77
%
Index- P/E- EPS (ttm)-2.06 Insider Own3.93% Shs Outstand19.55M Perf Week1.40%
Market Cap17.51M Forward P/E- EPS next Y- Insider Trans0.13% Shs Float18.78M Perf Month-39.49%
Income-30.42M PEG- EPS next Q-0.51 Inst Own14.86% Short Float7.19% Perf Quarter-51.07%
Sales4.49M P/S3.90 EPS this Y-0.50% Inst Trans-12.14% Short Ratio5.82 Perf Half Y-53.36%
Book/sh-0.01 P/B- EPS next Y- ROA-212.11% Short Interest1.35M Perf Year-45.73%
Cash/sh0.49 P/C1.84 EPS next 5Y- ROE-269476.55% 52W Range0.68 - 5.65 Perf YTD-77.50%
Dividend Est.- P/FCF- EPS past 5Y- ROI-58178.28% 52W High-84.15% Beta1.00
Dividend TTM- Quick Ratio1.01 Sales past 5Y148.40% Gross Margin82.51% 52W Low31.69% ATR (14)0.12
Dividend Ex-Date- Current Ratio1.01 EPS Y/Y TTM18.32% Oper. Margin-674.33% RSI (14)32.78 Volatility10.03% 15.32%
Employees30 Debt/Eq- Sales Y/Y TTM-7.49% Profit Margin-677.46% Recom1.00 Target Price17.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q46.37% Payout- Rel Volume0.97 Prev Close0.88
Sales Surprise- EPS Surprise8.11% Sales Q/Q-80.14% EarningsOct 01 BMO Avg Volume231.82K Price0.90
SMA20-12.27% SMA50-30.78% SMA200-57.07% Trades Volume177,801 Change1.77%
Date Action Analyst Rating Change Price Target Change
Jun-05-15Reiterated Canaccord Genuity Buy $4 → $6
Jan-12-15Reiterated ROTH Capital Buy $6 → $4
May-23-12Initiated Noble Financial Buy
Jan-23-07Initiated Next Generation Buy $5
Oct-07-24 04:15PM
Oct-02-24 06:54AM
03:00AM
Oct-01-24 07:30AM
Sep-30-24 09:01AM
07:30AM Loading…
Sep-26-24 07:30AM
Sep-09-24 07:30AM
Aug-28-24 07:30AM
Aug-23-24 04:52AM
Aug-22-24 07:30AM
Jun-21-24 08:00AM
04:32AM
Jun-20-24 07:30AM
Jun-13-24 06:52AM
Jun-12-24 07:30AM
12:00PM Loading…
May-20-24 12:00PM
May-16-24 03:05AM
01:46AM
May-15-24 07:30AM
May-09-24 07:30AM
May-02-24 07:30AM
Apr-30-24 07:30AM
Apr-14-24 03:00PM
Apr-09-24 08:59AM
Apr-08-24 12:02PM
07:30AM
Feb-28-24 07:30AM
Feb-16-24 10:00AM
12:55AM
Feb-15-24 07:30AM
07:30AM Loading…
Feb-09-24 07:30AM
Feb-05-24 07:30AM
Feb-01-24 04:00PM
Jan-30-24 08:00AM
Jan-11-24 01:38PM
Jan-08-24 10:33AM
Jan-03-24 08:00AM
Dec-23-23 05:00PM
Dec-20-23 07:30AM
Dec-18-23 04:15PM
Nov-15-23 03:01PM
03:29AM
Nov-14-23 07:30AM
Nov-09-23 07:30AM
Oct-24-23 04:50PM
Oct-23-23 07:30AM
Oct-19-23 08:45AM
07:30AM
Oct-18-23 07:30AM
Oct-16-23 07:30AM
Oct-13-23 04:15PM
Oct-03-23 08:35AM
Sep-29-23 01:34AM
Sep-28-23 07:30AM
Sep-22-23 04:00PM
Sep-07-23 04:00PM
07:30AM
Aug-10-23 07:30AM
Aug-08-23 07:30AM
Aug-07-23 07:30AM
Aug-04-23 07:30AM
Jul-11-23 07:30AM
May-30-23 07:30AM
May-17-23 01:39PM
01:33AM
May-16-23 08:45AM
07:30AM
May-15-23 09:05AM
May-11-23 05:25PM
04:15PM
May-09-23 05:45PM
07:30AM
May-08-23 04:04PM
May-01-23 04:00PM
Apr-27-23 07:30AM
Apr-25-23 07:30AM
Apr-19-23 07:30AM
Apr-18-23 07:30AM
Mar-02-23 07:30AM
Feb-28-23 07:30AM
Feb-15-23 07:30AM
Feb-10-23 07:30AM
Jan-26-23 05:45PM
Jan-19-23 07:30AM
Jan-18-23 07:30AM
Jan-10-23 07:30AM
Jan-05-23 07:30AM
Nov-14-22 08:55AM
07:30AM
Nov-10-22 08:55AM
Nov-09-22 06:45PM
05:16PM
Nov-08-22 07:25PM
Nov-07-22 05:15PM
Oct-31-22 09:30AM
Oct-27-22 07:05AM
Oct-24-22 05:32PM
Oct-20-22 07:30AM
Oct-17-22 07:30AM
Oct-13-22 07:30AM
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WILLS STEPHEN TExecutive VP and CFO/COOAug 01 '24Sale1.664,9998,274235,456Aug 02 05:01 PM
DEVEER ROBERT K JRDirectorApr 11 '24Buy2.126,00012,70340,845Apr 11 04:45 PM
DEVEER ROBERT K JRDirectorMar 06 '24Sale2.0011,70023,43434,845Mar 07 05:02 PM
WILLS STEPHEN TExecutive VP and CFO/COODec 06 '23Sale2.514,99812,563327,522Dec 08 05:30 PM
DUNTON ALAN WDirectorDec 04 '23Sale2.4820049645,074Dec 06 05:02 PM